Request for Covid-19 Impact Assessment of this Report
The United States Gene Therapy for Inherited Genetic Disorders market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gene Therapy for Inherited Genetic Disorders market, reaching US$ million by the year 2028. As for the Europe Gene Therapy for Inherited Genetic Disorders landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gene Therapy for Inherited Genetic Disorders players cover BioMarin Pharmaceutical Inc., bluebird bio Inc., Novartis AG, and Orchard Therapeutics Plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy for Inherited Genetic Disorders market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Research Institute
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapy for Inherited Genetic Disorders Market Size 2017-2028
2.1.2 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gene Therapy for Inherited Genetic Disorders Segment by Type
2.2.1 Eye Disorders
2.2.2 Hematological Disorders
2.2.3 Central Nervous System Disorders
2.2.4 Muscular Disorders
2.2.5 Others
2.3 Gene Therapy for Inherited Genetic Disorders Market Size by Type
2.3.1 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2017-2022)
2.4 Gene Therapy for Inherited Genetic Disorders Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institute
2.4.4 Others
2.5 Gene Therapy for Inherited Genetic Disorders Market Size by Application
2.5.1 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2017-2022)
3 Gene Therapy for Inherited Genetic Disorders Market Size by Player
3.1 Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Players
3.1.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2020-2022)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Players (2020-2022)
3.2 Global Gene Therapy for Inherited Genetic Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gene Therapy for Inherited Genetic Disorders by Regions
4.1 Gene Therapy for Inherited Genetic Disorders Market Size by Regions (2017-2022)
4.2 Americas Gene Therapy for Inherited Genetic Disorders Market Size Growth (2017-2022)
4.3 APAC Gene Therapy for Inherited Genetic Disorders Market Size Growth (2017-2022)
4.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size Growth (2017-2022)
4.5 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Country (2017-2022)
5.2 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022)
5.3 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Region (2017-2022)
6.2 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022)
6.3 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gene Therapy for Inherited Genetic Disorders by Country (2017-2022)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022)
7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders by Region (2017-2022)
8.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022)
8.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gene Therapy for Inherited Genetic Disorders Market Forecast
10.1 Global Gene Therapy for Inherited Genetic Disorders Forecast by Regions (2023-2028)
10.1.1 Global Gene Therapy for Inherited Genetic Disorders Forecast by Regions (2023-2028)
10.1.2 Americas Gene Therapy for Inherited Genetic Disorders Forecast
10.1.3 APAC Gene Therapy for Inherited Genetic Disorders Forecast
10.1.4 Europe Gene Therapy for Inherited Genetic Disorders Forecast
10.1.5 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Forecast
10.2 Americas Gene Therapy for Inherited Genetic Disorders Forecast by Country (2023-2028)
10.2.1 United States Gene Therapy for Inherited Genetic Disorders Market Forecast
10.2.2 Canada Gene Therapy for Inherited Genetic Disorders Market Forecast
10.2.3 Mexico Gene Therapy for Inherited Genetic Disorders Market Forecast
10.2.4 Brazil Gene Therapy for Inherited Genetic Disorders Market Forecast
10.3 APAC Gene Therapy for Inherited Genetic Disorders Forecast by Region (2023-2028)
10.3.1 China Gene Therapy for Inherited Genetic Disorders Market Forecast
10.3.2 Japan Gene Therapy for Inherited Genetic Disorders Market Forecast
10.3.3 Korea Gene Therapy for Inherited Genetic Disorders Market Forecast
10.3.4 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Forecast
10.3.5 India Gene Therapy for Inherited Genetic Disorders Market Forecast
10.3.6 Australia Gene Therapy for Inherited Genetic Disorders Market Forecast
10.4 Europe Gene Therapy for Inherited Genetic Disorders Forecast by Country (2023-2028)
10.4.1 Germany Gene Therapy for Inherited Genetic Disorders Market Forecast
10.4.2 France Gene Therapy for Inherited Genetic Disorders Market Forecast
10.4.3 UK Gene Therapy for Inherited Genetic Disorders Market Forecast
10.4.4 Italy Gene Therapy for Inherited Genetic Disorders Market Forecast
10.4.5 Russia Gene Therapy for Inherited Genetic Disorders Market Forecast
10.5 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Forecast by Region (2023-2028)
10.5.1 Egypt Gene Therapy for Inherited Genetic Disorders Market Forecast
10.5.2 South Africa Gene Therapy for Inherited Genetic Disorders Market Forecast
10.5.3 Israel Gene Therapy for Inherited Genetic Disorders Market Forecast
10.5.4 Turkey Gene Therapy for Inherited Genetic Disorders Market Forecast
10.5.5 GCC Countries Gene Therapy for Inherited Genetic Disorders Market Forecast
10.6 Global Gene Therapy for Inherited Genetic Disorders Forecast by Type (2023-2028)
10.7 Global Gene Therapy for Inherited Genetic Disorders Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 BioMarin Pharmaceutical Inc.
11.1.1 BioMarin Pharmaceutical Inc. Company Information
11.1.2 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 BioMarin Pharmaceutical Inc. Main Business Overview
11.1.5 BioMarin Pharmaceutical Inc. Latest Developments
11.2 bluebird bio Inc.
11.2.1 bluebird bio Inc. Company Information
11.2.2 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 bluebird bio Inc. Main Business Overview
11.2.5 bluebird bio Inc. Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Gene Therapy for Inherited Genetic Disorders Product Offered
11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Orchard Therapeutics Plc
11.4.1 Orchard Therapeutics Plc Company Information
11.4.2 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product Offered
11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Orchard Therapeutics Plc Main Business Overview
11.4.5 Orchard Therapeutics Plc Latest Developments
11.5 Spark Therapeutics Inc.
11.5.1 Spark Therapeutics Inc. Company Information
11.5.2 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Spark Therapeutics Inc. Main Business Overview
11.5.5 Spark Therapeutics Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Eye Disorders
Table 3. Major Players of Hematological Disorders
Table 4. Major Players of Central Nervous System Disorders
Table 5. Major Players of Muscular Disorders
Table 6. Major Players of Others
Table 7. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2017-2022)
Table 10. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2017-2022)
Table 13. Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Player (2020-2022)
Table 15. Gene Therapy for Inherited Genetic Disorders Key Players Head office and Products Offered
Table 16. Gene Therapy for Inherited Genetic Disorders Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Gene Therapy for Inherited Genetic Disorders Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Regions (2017-2022)
Table 21. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country (2017-2022)
Table 23. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2017-2022)
Table 25. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2017-2022)
Table 27. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2017-2022)
Table 29. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2017-2022)
Table 31. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2017-2022)
Table 33. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country (2017-2022)
Table 35. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2017-2022)
Table 37. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Gene Therapy for Inherited Genetic Disorders
Table 46. Key Market Challenges & Risks of Gene Therapy for Inherited Genetic Disorders
Table 47. Key Industry Trends of Gene Therapy for Inherited Genetic Disorders
Table 48. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Application (2023-2028)
Table 54. BioMarin Pharmaceutical Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 55. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 56. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. BioMarin Pharmaceutical Inc. Main Business
Table 58. BioMarin Pharmaceutical Inc. Latest Developments
Table 59. bluebird bio Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 60. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 61. bluebird bio Inc. Main Business
Table 62. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. bluebird bio Inc. Latest Developments
Table 64. Novartis AG Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 65. Novartis AG Gene Therapy for Inherited Genetic Disorders Product Offered
Table 66. Novartis AG Main Business
Table 67. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Novartis AG Latest Developments
Table 69. Orchard Therapeutics Plc Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 70. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product Offered
Table 71. Orchard Therapeutics Plc Main Business
Table 72. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Orchard Therapeutics Plc Latest Developments
Table 74. Spark Therapeutics Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 75. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 76. Spark Therapeutics Inc. Main Business
Table 77. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Spark Therapeutics Inc. Latest Developments
List of Figures
Figure 1. Gene Therapy for Inherited Genetic Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type in 2021
Figure 7. Gene Therapy for Inherited Genetic Disorders in Hospital
Figure 8. Global Gene Therapy for Inherited Genetic Disorders Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Gene Therapy for Inherited Genetic Disorders in Clinic
Figure 10. Global Gene Therapy for Inherited Genetic Disorders Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Gene Therapy for Inherited Genetic Disorders in Research Institute
Figure 12. Global Gene Therapy for Inherited Genetic Disorders Market: Research Institute (2017-2022) & ($ Millions)
Figure 13. Gene Therapy for Inherited Genetic Disorders in Others
Figure 14. Global Gene Therapy for Inherited Genetic Disorders Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application in 2021
Figure 16. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Player in 2021
Figure 17. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Gene Therapy for Inherited Genetic Disorders Market Size 2017-2022 ($ Millions)
Figure 19. APAC Gene Therapy for Inherited Genetic Disorders Market Size 2017-2022 ($ Millions)
Figure 20. Europe Gene Therapy for Inherited Genetic Disorders Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size 2017-2022 ($ Millions)
Figure 22. Americas Gene Therapy for Inherited Genetic Disorders Value Market Share by Country in 2021
Figure 23. Americas Gene Therapy for Inherited Genetic Disorders Consumption Market Share by Type in 2021
Figure 24. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application in 2021
Figure 25. United States Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region in 2021
Figure 30. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application in 2021
Figure 31. China Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country in 2021
Figure 38. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type in 2021
Figure 39. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application in 2021
Figure 40. Germany Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application in 2021
Figure 48. Egypt Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Gene Therapy for Inherited Genetic Disorders Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 54. APAC Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 55. Europe Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 57. United States Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 58. Canada Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 61. China Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 62. Japan Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 63. Korea Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 65. India Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 66. Australia Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 67. Germany Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 68. France Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 69. UK Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 70. Italy Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 71. Russia Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 72. Spain Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 75. Israel Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Gene Therapy for Inherited Genetic Disorders Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...